Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 30, 2017 07:00 ET | Source: ContraFect Corporation

ContraFect Chairman Steven C. Gilman Returns from Temporary Medical Leave

YONKERS, NY--(Marketwired - May 30, 2017) - ContraFect Corporation (NASDAQ: CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics...
August 09, 2016 07:00 ET | Source: ContraFect Corporation

ContraFect Announces Second Quarter 2016 Results

YONKERS, NY --(Marketwired - August 09, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
June 01, 2016 07:00 ET | Source: ContraFect Corporation

ContraFect to Present at Jefferies 2016 Healthcare Conference

YONKERS, NY--(Marketwired - June 01, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of...
September 21, 2015 14:04 ET | Source: Provista Diagnostics, Inc.

Provista Diagnostics Announces Reelection of the Company's Board of Directors

NEW YORK, NY, Sept. 21, 2015 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately-held molecular diagnostics company developing and commercializing a new generation of proprietary blood-based...